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The role of molecular chaperonins in warm
ischemia and reperfusion injury in the steatotic
liver: A proteomic study
Venkataswarup Tiriveedhi1,6*, Kendra D Conzen1, Jane Liaw-Conlin1, Gundumi Upadhya1, James Malone2,
R Reid Townsend2,3, Robnet Kerns2, Jianluo Jia1, Krista Csontos2, Sabarinathan Ramachandran1,
Thallachallour Mohanakumar1,4, Christopher D Anderson5 and William C Chapman1,7*
Abstract
Background: The molecular basis of the increased susceptibility of steatotic livers to warm ischemia/reperfusion
(I/R) injury during transplantation remains undefined. Animal model for warm I/R injury was induced in obese
Zucker rats. Lean Zucker rats provided controls. Two dimensional differential gel electrophoresis was performed
with liver protein extracts. Protein features with significant abundance ratios (p < 0.01) between the two cohorts
were selected and analyzed with HPLC/MS. Proteins were identified by Uniprot database. Interactive protein
networks were generated using Ingenuity Pathway Analysis and GRANITE software.
Results: The relative abundance of 105 proteins was observed in warm I/R injury. Functional grouping revealed
four categories of importance: molecular chaperones/endoplasmic reticulum (ER) stress, oxidative stress,
metabolism, and cell structure. Hypoxia up-regulated 1, calcium binding protein 1, calreticulin, heat shock protein
(HSP) 60, HSP-90, and protein disulfide isomerase 3 were chaperonins significantly (p < 0.01) down-regulated and
only one chaperonin, HSP-1was significantly upregulated in steatotic liver following I/R.
Conclusion: Down-regulation of the chaperones identified in this analysis may contribute to the increased ER stress
and, consequently, apoptosis and necrosis. This study provides an initial platform for future investigation of the role
of chaperones and therapeutic targets for increasing the viability of steatotic liver allografts.
Keywords: Ischemia repurfusion injury, Two dimensional gel electrophoresis, Mass spectrometry, Liver
transplantation, Chaperonins, Endoplasmic reticulum (ER) stress
Background
Approximately 6,000 liver transplants are performed
annually in the United States (U.S. Scientific Registry and
Transplant Recipients 2008). The shortage of available
organs, remains a major problem and contributes to a
waiting list mortality greater than 110 deaths per 1000
patient years on the waiting list [1]. The current donor
shortage is further compounded by the increasing
prevalence of hepatic steatosis in potential donors. Fatty
infiltration of the liver is now the most common adverse
condition in potential donors, with a prevalence of 13-50%
in some populations [2,3]. Steatotic livers are more sus-
ceptible to ischemia/reperfusion (I/R) injury induced by
both warm and cold ischemic periods during transplant-
ation, which directly lead to higher rates of primary non-
function and delayed graft function [4-6]. Initial primary
nonfunction predisposes to three-fold increased incidence
of early rejection and graft loss within three months of
transplantation [7]. The severity of I/R injury is associated
with the degree of fatty infiltration. Severely steatotic livers
(>60% steatosis) are contraindicated for liver transplant-
ation [5,6]. Although, moderate steatosis (30-60%) is a
relative contraindication for transplantation, however, due
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to the limited availability of the organs, these allografts are
also being used with greater frequency in several trans-
plant centers [2].
Efforts have been made to understand the molecular
mechanisms responsible for poor graft function in stea-
totic livers. However, research to date has been limited
by focus on individual pathways or molecules. Given the
numerous intracellular changes which are likely to occur,
a global molecular approach is required to identify med-
iators of injury. Proteomics provides one approach to
identify and study potential biomarkers and mediators
and offers the advantage of elucidating overall patterns
of injury-induced changes at the protein level, including
both changes in relative protein abundance and post-
translational modifications of proteins [8,9]. Proteomics
has been successfully employed in the study of various
liver injury models and models of ischemia/reperfusion
(I/R) [10-15]. High levels of oxidative stress and
decreased levels of antioxidant proteins have been impli-
cated as important mediators of injury due to ethanol-
induced steatosis [16]. Steatosis has been implicated to
induce changes in the mitochondrial proteome [17]. The
I/R injury in other organs is shown to increase mito-
chondrial permeability, contributing to activation of
apoptotic pathways [18]. Studies have demonstrated that
proteins and enzymes involved in lipid and energy me-
tabolism, redox signaling and oxidative stress responses
were affected during cold and warm I/R phases in trans-
plantation [19]. Despite research into the mechanisms of
injury in liver I/R and in steatosis, a comprehensive
study on the proteome in liver subjected to I/R has not
yet been studied. Therefore, we performed a proteomic
analysis on fatty rat livers following a period of warm is-




Male obese (n = 3) and lean (control group, n = 3) Zucker
rats were purchased from Harlan Laboratories (Indian-
apolis, IN). Upon arrival at the pathogen-free barrier fa-
cility at Washington University in St. Louis, rats weighed
280 to 310 grams and were 8–11 weeks old. Animals
had access to standard chow ad libitum and were main-
tained on a 12 h light-dark cycle. Animal protocols were
approved by the Animal Studies Committee of Washing-
ton University in St. Louis and experiments were per-
formed in accordance with the National Institutes of
Health Guidelines for the Use of Laboratory Animals.
Liver ischemia
A model of selective (70%) hepatic warm ischemia was
used. Anesthesia was induced with 3% inhaled isoflurane
and maintained with 1.5 - 2% isoflurane. Animals were
placed on a warming table and the abdominal wall was
shaved and sterilized with betadine. Laparotomy was
performed through a midline incision. The portal triad
was dissected free of surrounding tissue. Portal vein and
hepatic artery branches to the left and median hepatic
lobes were identified and occluded with a microvascular
clamp for 45 min (Fine Science Tools, Foster City, CA).
This method of partial hepatic ischemia prevents mesen-
teric venous congestion and permits decompression of
the gut through the right hepatic vessels. Observed
blanching of the left and median hepatic lobes con-
firmed appropriate placement of the clamp. The abdo-
men was covered with saline-moistened gauze during
ischemia. Upon portal clamp removal, evidence of reper-
fusion was observed through immediate color change of
the left and median lobes. The abdominal wall was
closed with a running 4–0 monofilament suture. After
1 h of reperfusion, a median lobectomy was performed
by ligation of the median lobe portal pedicle with a 4–0
silk suture. The left lobe was removed in a similar man-
ner after two hours of reperfusion. All tissue samples
were snap frozen in liquid nitrogen and stored at-80°C
until processing.
Sample preparation
The sample preparation for two-dimensional differential
gel electrophoresis was performed with liver protein
extracts as previously described [20]. Individual pieces of
frozen liver tissue (approximately 1 cm2) from lean or
obese animals were covered with liquid nitrogen in a pre-
cooled Biopulverizer (Biospec Products Inc., Bartsville,
OK) and crushed to a fine powder. Each sample was solu-
bilized in lysis buffer (Tris-HCl pH 8.5 (30 mM), 7 M
urea, 2 M thiourea, and 4% CHAPS), and the total pro-
tein content was determined using the Advanced Protein
Assay (Cytoskeleton, Inc.). A total pool was generated
using equal amounts of each pool to represent all proteins
found in the study. An aliquot containing 50 μg of protein
from each sample was diluted to 50μL with lysis buffer
(Tris-HCl pH 8.5 (30 mM), 7 M urea, 2 M thiourea, and
4% CHAPS) and labeled with 400 pmol of charge-
matched cyanine dyes (GE health care, Pittsburgh, PA) 3-
[(4-carboxymethyl) phenylmethyl]-3-ethyloxacarbocyanine
halide N-hydroxysuccinimidyl ester (Cy2,) for lean, or
1-(5-carboxypentyl)-10-methylindodicarbocyanine halide
N-hydroxysuccinimidyl ester (Cy5) for obese. All chemicals
unless otherwise specified were obtained from Sigma-
Aldrich (St. Louis, MO). The total pool sample was labeled
using 1-(5-carboxypentyl)-10-propylindocarbocyanine hal-
ide N-hydroxysuccinimidyl ester (Cy3) for combined pro-
tein pool as internal standard for intergel comparison. The
pool consisted of all 3 samples and was prepared by com-
bining 50 μg of each individual sample. All labeling reac-
tions were carried out for 45 min at 4°C and protected
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from light. The reaction was quenched with 10 nmol of
lysine for 10 min (4°C, protected from light). Labeled lean
and obese samples were combined with a total pool aliquot
and the resulting mixture was diluted by addition of
300 mL of rehydration buffer (7 M urea/2 M thiourea, 4%
CHAPS, 0.5% v/v ampholytes (pH 3–10)) [21].
Two dimensional electrophoresis (2-de) and imaging
Each combined tripartite-labeled sample (450 μL final
volume) was rehydrated into 24 cm, 3–10 NL IPG strips
(GE Healthcare, Piscataway, NJ) under low voltage
(100 V) for 12 h, followed by isoelectric focusing (IEF)
using a Protean IEF cell (Bio-Rad Labs, Hercules, CA)
for a total of 65.5 kVh (using a three-step voltage proto-
col: 500 V and held for 500 Vh, 1000 V and held for
1000 Vh, 8000 V, and held for 64,000 Vh). After focus-
ing, proteins were reduced by placing the IPG strips in
10 mL of equilibration buffer (10 mL, 50 mM Tris (pH
8.8), 6 M urea, 30% glycerol, 2% SDS, bromophenol
blue) containing freshly prepared DTT (50 mg) for
15 min at room temperature. The proteins were then
alkylated by adding iodoacetamide (600 mg in 10 mL of
equilibration buffer). IPG strips were then rinsed with
1X SDS running buffer (25 mM Tris, 192 mM glycine,
0.1% SDS) and layered on 10-20% polyacrylamide gels
and sealed with agarose (1% w/v in 16x running buffer).
Commercially prepared gels (Jule, Inc., Milford, CT)
were cast between low-fluorescence glass plates using
bind-silane (GE Healthcare, Piscataway, NJ) to attach
the gel to one plate as per the manufacturer’s instruc-
tions. Second-dimension SDS-PAGE separation was car-
ried out on all gels simultaneously using 5 W/gel for the
first 15 min followed by 1 W/gel for 17 h with circulat-
ing buffer (20°C) in the lower buffer chamber. Images of
the labeled proteins in each gel were generated using a
Typhoon Imager (GE Healthcare, Piscataway, NJ) and
the following excitation/emission wavelengths for
each dye (488/520 nm for Cy2, 520/580 nm for Cy3, and
620/670 nm for Cy5). After image generation, the nonsila-
nized glass plate was removed and the gels were placed
in fixing solution (33% ethanol, 7.5% acetic acid) for 2 h.
Gels were then rinsed with deionized water (18 MΩ)
for 15 min and stored in water-filled, sealed bags at
47°C. All steps were performed to minimize exposure
to ambient light.
Gel image analysis
Protein features with significant abundance ratios (fold-
change) between experimental groups (p < 0.01) were
selected by gel image analysis (DeCyder v. 6.5) and ana-
lyzed with high performance liquid chromatography
(HPLC)/mass spectometry (MS). ImageQuant (Molecu-
lar Dynamics from GE Healthcare, Piscataway, NJ) soft-
ware was used to crop the gel images and remove
portions of the image corresponding to the IPG strip,
the spacers between the gel plates, and any remaining
dye front from the electrophoresis. The DeCyder (v. 6.5)
DIA (difference in-gel analysis) module was used to
identify gel feature boundaries and calculate abundance
ratios using a normalization algorithm that was applied
as previously described [22-24]. Standard parameters
were used to determine boundaries estimating 10,000
features per image. Gel artifacts were removed by soft-
ware from each gel image using a peak volume filter set
at 10,000. Additional gel artifacts (e.g. water spots, dust
particles) were excluded manually. Images were com-
pared across multiple gels using the DeCyder BVA (Bio-
logical Variation Analysis) module. This analysis
matched features in the pool images from each gel, using
this sample as a quantitative reference for protein fea-
tures in the remaining images allowing quantitative
comparison of features in all images in the experiment.
The DeCyder Extended Data Analysis (EDA) module
was used to perform t-test analysis and generate heat-
maps. Matched features with significant differences in
abundance ratios (p <0.01) or with abundance ratios >
1.5 (p < 0.05) and 100% gel presence were selected for
further analysis.
Gel digestion, preparation of peptides and mass
spectrometric analysis
Selected features were excised robotically (ProPic, Gen-
omic Solutions, Ann Arbor, MI) using a triangulation al-
gorithm implemented with in-house software. Proteins
in the gel pieces were digested in situ with trypsin [25],
and stored at −80°C until analyzed by mass spectrom-
etry. Samples were analyzed using a nanoflow (200 nl/
min) pulse-free liquid chromatograph, interfaced to a
quadrupole time-of-flight mass spectrometer (Q-STAR
XL, Applied Biosystems, Foster City, CA) using a Pico-
View system (New Objective, Woburn, MA), or nano-
reversed-phase HPLC interfaced to an electrospray-
linear ion trap-Fourier transform ion cyclotron mass
spectrometer (LTQ-FT, Thermo-Finnigan, Ringoes, NJ)
operated as previously described [26]. The MS and MS/
MS data were collected in the profile mode. The “raw”
files were processed using MASCOT Distiller, version
2.1.1.0 (Matrix Science, Oxford, U.K.) and searched
using MASCOT version 2.3.02 against the UniProt Rat
database (downloaded November 21, 2011) with 41, 601
entries (Additional file 1: Table S1). The resulting DAT
files were imported into Scaffold, ver. 3.5.1 (Proteome
Software, Portland, OR) to identify proteins with greater
than or equal to 95% confidence and to determine the
spectral counts for each protein. The detailed mass spec-
trometry and peptide data are summarized in Additional
file 1: Table S1.
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Network and pathway analysis
Proteins identified from the Uniprot database were
imported into Ingenuity Pathway Analysis (IPA) software,
version 6.3 (Ingenuity Systems,Inc., Redwood city, CA) to
generate interactive protein networks. Duplicate GI num-
bers were manually removed prior to loading. GI numbers
were loaded into IPA; proteins not recognized by IPA were
removed from analysis. A network analysis was performed
with limitations set at 35 proteins; direct and indirect rela-
tionships were permitted. Core analysis of the protein set
generated, producing 9 interactome networks.
Gene networks were created by submitting gene symbol
lists to the GRANITE web application (Gene RelAtional
Network of InTeracting Elements), a tool to generate
gene relational networks (http://bioinformatics.wustl.edu/
webTools/GraniteGeneSearch.do). The “enhanced” GRA-
NITE function was used to discover genes not present in
but are targets of or interact with submitted gene sets.
Gene sets combined with any discovered genes were
reloaded into GRANITE to complete connections from
discovered genes to genes in the original list. Raw and
filtered GRANITE output was directly loaded into Cytos-
cape for network integeration and visualization [27].
Results
Identification of protein targets in warm I/R injury
To analyze the differences in the proteome leading to
warm I/R injury in steatotic livers, total protein was col-
lected from lean and obese Zucker rats. A 50 μg protein
sample individually collected from lean and obese rats
subjected to I/R injury were labeled with cyanine dye
Cy2 and Cy5, respectively, and subjected to 2-DE with
an IEF range of pH 3 to 10. The proteome of lean and
obese rats were compared following 1 and 2 h of reper-
fusion (Figure 1A). The total protein pool of 25 μg was
treated with cyanine dye Cy3 and run on 2-DE as in-
ternal standard to compare between intergel variability.
The differential in gel analysis (DIA) module for soft-
ware Decyder v 6.5 (Amersham) was used to calculate
the protein spot volumes and normalized volume ratio
for each differentially labeled co migrated protein
(Figure 1). The values of 2 standard deviations of the
mean volume ratios were between 1.3 and 1.7, and only
features with greater than 1.5 fold changes in volume in
both gels per time point were defined as altered. As
shown in lower panel of Figure 1B-D, there is no signifi-
cant difference between the 1 and 2 hr reperfusion of
lean rats, and similarly there is no significant difference
between the 1 and 2 hr reperfusion of obese rats.
A heat map generated from the DeCyder Extended Data
Analysis (EDA) module (Figure 2A) was utilized for hier-
archical clustering and additional statistical analysis. As
shown in Figure 2B, an initial analysis showed 5,236 fea-
tures on the gels which have a volume ratios (spot
frequency/spot volume ratios) variance of at least greater
than 1.5. This ratio was taken as a threshold value above
or below which spot volume observed in the analytical gels
were considered significant. The standardized abundances
of all features matched protein features were compared
across four analytical protein gels (1 and 2 hrs reperfusion
of lean and obese animals), and Students’ t-test was per-
formed with the DeCyder biological variance analysis
(BVA) module to validate the significance of the detected
difference between spot volumes at p < 0.01. A total of 269
features were selected from the initial automated analysis.
Manual inspection for artifact elimination (due to streaks
and staining contamination), and further statistical ana-
lysis, produced 84 features of interest (Additional file 1:
Table S1) for feature excision, in-situ gel digestion and
identification using tandem mass spectrometry with data-
base searching.
Identification of the differentially regulated proteins by
mass spectrometry
The 84 features of interest identified by ANOVA analysis
on the 2-DE were excised subjected to in-gel digestion
with trypsin, and the peptide pools from each excised
feature were analyzed using nano-LC-MS, as described
under ‘Materials and Methods’. The database searches
were qualified using the Protein Prophet algorithm (95%
protein probability) within the SCAFFOLD software.
The analysis identified 106 proteins with 453 peptides in
the 84 ‘differential’ features (see Additional file 2: Table
S2 for peptide sequences and supporting MS data).
These lead protein targets were utilized for further ana-
lysis to identify the biochemical pathways involved in
the I/R injury.
Differential expression of ER stress related molecular
chaperones in steatotic liver after I/R compared to lean
liver
No differential gene expression was observed between 1
and 2 h of reperfusion in either the steatotic liver or the
lean liver. Therefore, steatotic liver tissue from 1 h and
2 h reperfusion were pooled, and lean liver tissue
obtained after 1 or 2 h reperfusion were pooled. All fur-
ther analysis was performed to compare protein expres-
sion between fat and lean liver samples. One hundred
four proteins with significant abundance ratios were
identified. A PubMed/Medline search was performed for
each protein by protein name and corresponding gene
ID. Based on published literature in this database, pro-
teins were grouped according to functional category.
Functional grouping revealed four categories of import-
ance: molecular chaperones/endoplasmic reticulum (ER)
stress, oxidative stress, metabolism, and cell structure
(Figure 3). Hypoxia up-regulated 1 (Hyou1, abundance
ratio −1.39), calcium binding protein 1 (Cabp1, -1.37),
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Figure 1 (A) Isoelectric focusing 2D gel (pH 3–10). Soluble protein (500 μg) was loaded onto the gel. A representative gel from the total
protein collected from of 2 hrs reperfusion injury of liver collected from the obese rat is shown; (B-D) Representative features with abundance as
analyzed by three-dimensional simulation and identified by Decyder v6.5 with at least 2 fold abundance.
Figure 2 (A) Heat map generated from 84 protein features selected on 2-DE for analysis; (B) Rationale adopted in identifying the
features of interest on 2-DE.
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calreticulin (Calr, -1.31), heat shock protein 60 (Hsp60,
-1.14), heat shock protein 90 (Hsp90B1, -1.33), and pro-
tein disulfide isomerase 3 (Pdia3, -1.92) were chapero-
nins down-regulated in steatotic liver following I/R.
Only one chaperonin, heat shock protein 1 (Hspd1,
1.89), was significantly upregulated.
Ingenuity pathway analysis identifies four molecular
chaperone mediated pathways as the critical targets of
I/R injury
Ingenuity Pathway Analysis was used to determine rela-
tionships of our known significant proteins with each
other and other known proteins in the literature which
did not show differential expression in our project. IPA
generated nine networks, with 106 proteins mapping
into at least one of these networks (Figure 4). A network
of great significance was that representing cellular as-
sembly and organization, protein degradation, with con-
nections to more than 21 identified proteins with
differential expression from the liver samples. This
included four of the chaperonins previously identified:
Hyou1, Calr, HSP90B1, and Pdia3. These four proteins
were indirectly related through interactions with Akt, a
well-known serine/threonine kinase, and X-box binding
protein-1 (spliced) (XBP-1(s)), a key mediator in one of
three ER stress response pathways. A total of 97 proteins
were identified in functional or canonical pathways. Not
surprisingly, the greatest functional categories and ca-
nonical pathways with differential profiles between stea-
totic and lean liver were those involving amino acid
metabolism and small molecule biochemistry.
Discussion
The recent genomic revolution has resulted in a para-
digm drift in the comprehensive analysis of biological
processes and biochemical regulators. A continuous
body of literature strongly indicating a non-predictive
correlation between mRNA and protein level expression
[28], along with posttranscriptional modifications lead-
ing to control in the rate of synthesis and half-life of
proteins place [29] an increased importance on the dir-
ect measurement of the protein expression by proteomic
techniques to analyze the biochemical signaling path-
ways. In this report using various proteomics based
approaches we determine the key role of regulatory mo-
lecular chaperonins in the I/R injury in the setting of
liver steatosis.
The demand for liver allografts remains a challenging
problem for transplant centers in the US and across the
globe, especially with the increasing prevalence of hep-
atic steatosis in the donor population [30]. Attenuation
of steatosis-associated ischemia/reperfusion injury is an
important strategy for reducing allograft shortages.
Proteomic analysis is an important tool for large-scale
analysis of cellular changes induced through various in-
jury models, including that of hepatic ischemia . This
particular analysis revealed that the proteome profile of
steatotic liver following a period of warm ischemia/
reperfusion significantly differs from that of lean liver.
Some functional groups, such as those involved with
amino acid metabolism, fatty acid metabolism, and cellu-
lar structure, are expected to be significantly different in
steatotic liver, regardless of I/R injury. A novel finding,
however, was the significant down-regulation of multiple
molecular chaperones. Chaperonins have important
roles in protein folding and structure [31]. Disruptions
in cellular homeostasis can cause perturbations in
protein processing, resulting in an accumulation of
unfolded proteins. This triggers the “unfolded protein
response” (UPR), or endoplasmic reticulum (ER stress)
response, a response to cellular stress which can lead
to adaptation or trigger apoptotic pathways [32]. Cha-
peronins reduce ER stress by stabilizing proteins
which become unfolded during periods of cellular stress
(e.g., I/R). Pdia3 encodes ERp57, a known molecular
chaperone with well-established interactions with calreti-
culin and their role in antigen-processing/loading of
MHC class I molecules [33,34]. ERp57 is also known to
regulate Grp78, a key molecular chaperone in initiating
one of three ER stress signaling cascades [35]. The
chaperonin subset of proteins, with these molecules in
particular, represent potential therapeutic targets for
mitigating I/R injury.
The Akt pathway, a serine/threonine kinase, has been
shown to play an important role in various types of is-
chemia/reperfusion. Although it did not show significant
differential expression at the reperfusion time points
analyzed in our study, Akt is indirectly related to mul-
tiple chaperonins which do play a significant role in pro-
tein folding and processing, and have implicated roles in
endoplasmic reticulum stress in other models. Akt has
Figure 3 Proteins of chaperonin family which demonstrated
significant change in expression profile between lean and
obese animals.
Tiriveedhi et al. BMC Biochemistry 2012, 13:17 Page 6 of 9
http://www.biomedcentral.com/1471-2091/13/17
also been shown to play a role in ER stress. Given these
relationships which we have identified, it is likely that
ER stress plays a role in the greater injury sustained by
steatotic liver following intervals of ischemia/reperfusion
[36]. Also, certain key mediators of the unfolded protein
response (Grp78, IRE-1a, XBP-1(s), ATF4, and CHOP)
are shown to be upregulated in both a murine model of
hepatic warm I/R and a rat liver transplant model [37].
The potential role of chaperones as drug targets has
been well established. Previous studies in our laboratory
using a chaperones targeting small chemical molecule,
taurine-conjugated ursodeoxycholic acid (TUDCA), has
shown to decrease ER stress response and decrease is-
chemia repurfusion injury in animal models of steatotic
liver allografts [38]. The role of chaperones in ischemia
injury has also been established in other transplant mod-
els such as cardiac myocytes [39]. Not just limited to
transplant settings, but in other disease states such as
malaria, chaperones are considered as important drug
targets [40]. However, in our initial study along with
chaperones/ER stress protein group we have also
identified other protein groups such as oxidative stress,
metabolism, and cell structure. Although, it is currently
unclear of their potential role in drug targeting these
protein groups in ameliorating I/R injury and enhancing
survival of steatotic liver allografts, future research on
these protein groups could offer novel molecular targets.
Certain inherent limitations with 2-DE based proteo-
mics approaches associated with artifacts and database
subset mapping in identifying exact target proteins [41]
warrants further direct cell based functional studies to
validate our current findings. Lean liver tissue served as
the comparison, or control, for steatotic liver subjected
to warm ischemia and a short period of reperfusion;
however, it might be revealing to compare these samples
to liver tissue not subject to I/R. Samples obtained at
additional reperfusion times would help establish a trend
in protein expression profiles. In spite of limitations we
still consider our current study to add new insights and
further research to study the functional basis and poten-
tial chaperonin-based therapeutic strategies to enhance
long term survival of the liver allografts.
Figure 4 Ingenuity Pathway Analysis was used to define potential relationships of interest between proteins identified in the
proteomic analysis.
Tiriveedhi et al. BMC Biochemistry 2012, 13:17 Page 7 of 9
http://www.biomedcentral.com/1471-2091/13/17
Conclusion
In conclusion, using a broad-based proteome analysis,
we identified key differences between ischemic responses
in steatotic and lean livers. Down-regulation of the cha-
peronins identified in this analysis may contribute to the
increased levels of endoplasmic reticulum stress and,
consequently, apoptosis and necrosis observed in steato-
tic livers compared to lean livers. The proteins identified
in this report, provide an initial platform for investigat-
ing the role of molecular chaperones in I/R injury in
fatty liver and provide potential therapeutic targets for
increasing viability of steatotic liver allografts.
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